{
    "organizations": [],
    "uuid": "d4e188c3e25515fcc85155e371139b55e2f2d33c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-exemplar-genetics-rare-neurologica/brief-exemplar-genetics-rare-neurological-disease-model-cleared-by-fda-for-commercial-research-use-idUSFWN1RT0H7",
    "ord_in_thread": 0,
    "title": "BRIEF-Exemplar Genetics Rare Neurological Disease Model Cleared By FDA For Commercial Research Use",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - Intrexon Corp:\n* EXEMPLAR GENETICS RARE NEUROLOGICAL DISEASE MODEL CLEARED BY FDA FOR COMMERCIAL RESEARCH USE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-16T19:01:00.000+03:00",
    "crawled": "2018-04-17T12:31:25.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "intrexon",
        "corp",
        "exemplar",
        "genetics",
        "rare",
        "neurological",
        "disease",
        "model",
        "cleared",
        "fda",
        "commercial",
        "research",
        "use",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}